Intas And Arecor Ally On Value-Added Development
Accord To Market Reformulated Product Based On Arestat Proprietary Technology
Intas and Arecor have struck an exclusive licensing deal that will see the pair use Arecor’s proprietary Arestat formulation technology to develop value-added medicines, in particular for use outside of the hospital setting.
